Feedback / Questions
Imfinzi (durvalumab) - AstraZeneca
Imjudo (tremelimumab-actl) - AstraZeneca, Pfizer
Padcev (enfortumab vedotin-ejfv) - Astellas, Pfizer
Imfinzi + tremelimumab + Padcev: Data from P3 VOLGA trial (NCT04960709) for MIBC in H2 2025
(AstraZeneca)
-
Feb 6, 2025 -
Q4 & FY2024 Results
P3 data
•
Bladder Cancer • Genito-urinary Cancer • Oncology • Urothelial Cancer
https://www.astrazeneca.com/content/dam/az/PDF/2024/fy/Full-year-and-Q4-2024-results-clinical-trials-appendix.pdf
Feb 6, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious